David Hung's Net Worth

$214 Million

Estimate Recalculated Aug 11, 2025 08:04PM EST

Who is David Hung

David Hung has an estimated net worth of $214 Million. This is based on reported shares across multiple companies, which include Nuvation Bio Inc., NovoCure Ltd, ESTABLISHMENT LABS HOLDINGS INC., ARYA SCIENCES ACQUISITION CORP., Axovant Sciences Ltd., Opexa Therapeutics, Inc., and MEDIVATION, INC..

SEC CIK

David Hung's CIK is 0001310880

Past Insider Trading and Trends

2021 was David Hung's most active year for acquiring shares with 7 total transactions. David Hung's most active month to acquire stocks was the month of May. 2012 was David Hung's most active year for disposing of shares, totalling 20 transactions. David Hung's most active month to dispose stocks was the month of August. 2021 saw David Hung paying a total of $20,000,000.00 for 60,037,550 shares, this is the most they've acquired in one year. In 2015 David Hung cashed out on 234,140 shares for a total of $26,092,708.55, their largest year based on trade value.

Loading...

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Nuvation Bio Inc.

PRESIDENT AND CEO
Updated Mar 04, 2024
2.00MFeb 29
60.78MMar 02 - Feb 28
60.65MFeb 28
390.23KMar 09
Feb 10
Showing 6 results

NovoCure Ltd

Investor
Updated Jun 06, 2024
19.42KJun 05
12.55KJun 07
13.49KJun 08
8.21KJun 09
11.00KJun 10
9.70KMay 22
45.14KMay 31
Showing 8 results

ESTABLISHMENT LABS HOLDINGS INC.

Investor
Updated May 27, 2020
10.00KMay 26
10.00KJun 03
Showing 3 results

ARYA SCIENCES ACQUISITION CORP.

Investor
Updated Jul 06, 2020
Jul 01
Showing 2 results

Axovant Sciences Ltd.

Principal Executive Officer
Updated Jan 03, 2018
2.00MDec 29
Apr 17
4.00MApr 07
Showing 4 results

Opexa Therapeutics, Inc.

Investor
Updated Apr 07, 2011
20.50KApr 05
17.89KApr 30
Sep 10
Aug 25 - Aug 26
Aug 20
78.11KFeb 06
Aug 11
55.00KJun 26
May 06
45.00KJun 18
35.00KJun 15
Showing 12 results

MEDIVATION, INC.

President and CEO
Updated Sep 30, 2016
Sep 28
Sep 15
Form 4/A854.09K
Mar 04
1.90MFeb 18 - Feb 29
Feb 04
Dec 03
ScheduledMar 02
ScheduledFeb 26
114.00KFeb 17
968.93KFeb 09
ScheduledFeb 04
ScheduledJan 20
Oct 16 - Dec 03
133.00KFeb 18
1.06MFeb 04
Form 4/A50.00KJan 27
ScheduledJan 27
Dec 03
Nov 07
ScheduledJul 05
ScheduledApr 23
ScheduledApr 18 - Apr 22
ScheduledApr 11
ScheduledApr 05
155.00KDec 17
Dec 07 - Dec 10
ScheduledOct 04
Form 4/ASep 28
Sep 28
ScheduledSep 04
ScheduledJul 03
ScheduledMay 14
ScheduledFeb 07 - Feb 08
1.43MDec 09
ScheduledFeb 22 - Feb 24
1.57MDec 15
187.50KDec 15
ScheduledDec 07
ScheduledSep 09 - Sep 10
ScheduledJun 30 - Jul 01
ScheduledMar 18
ScheduledDec 03
150.00KOct 31
ScheduledSep 25
ScheduledJun 09
ScheduledMar 03
ScheduledDec 03
370.00KOct 01
ScheduledSep 19
ScheduledJun 05
ScheduledMar 16
150.00KOct 31
1.74MApr 05
1.73MJun 08
86.06KApr 04
96.12KDec 17
Showing 58 results